TWICL (8/28/26) - 2,500 Pages of Rescheduling Testimony, $CURA vs. $ACB, and New York's High Art

Is the DEA's surgical strategy at the rescheduling hearing setting the stage for Schedule III? On this edition of This Week in Cannabis Live, the gang unpacks the massive 2,500-page rescheduling transcript, the ongoing corporate proxy battle between Curaleaf ($CURA) and Aurora ($ACB), and how mainstream anti-cannabis PR is shaping public opinion. Plus, the crew sits down with special guest Rachel Bell, Curator of High Art at Gotham, to discuss her recent profile in The New Yorker, how to...